Taro Pharmaceutical Industries Ltd (NYSE:TARO)

67.51
Delayed Data
As of Jul 02
 +0.06 / +0.09%
Today’s Change
56.07
Today|||52-Week Range
99.69
-23.22%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Taro Pharmaceutical Industries Ltd have a median target of 96.00, with a high estimate of 96.00 and a low estimate of 96.00. The median estimate represents a +42.20% increase from the last price of 67.51.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in Taro Pharmaceutical Industries Ltd. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$1.49
Sales
$165.4M
Reporting Date
Aug 06

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 4.93%
 
 
 
 
 
 
Growthannually 3.15%
 
 
 
 
 

Sales

Growthquarterly -5.45%
 
 
 
 
 
 
Growthannually 6.44%
 
 
 
 
 
Key to the earnings and sales forecast charts.